Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT07096778 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma Refractory
Multiple Myeloma in Relapse

Interventions

DRUG: Inobrodib
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

CellCentric Ltd.